Brokerages Set Definitive Healthcare Corp. (NASDAQ:DH) Target Price at $4.73

Key Points

• Definitive Healthcare Corp. has received a consensus rating of "Hold" from six analysts, with one sell rating, four hold ratings, and one buy rating. The average target price is $4.7333.
• Institutional investors own 98.67% of the company's stock, with Wells Fargo and Barclays increasing their stakes significantly in the last quarter.
• The stock is currently trading at $4.01, with a twelve-month low of $2.15 and a high of $5.68, reflecting a 3.1% increase in recent trading.

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been given an average rating of "Hold" by the six ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $4.7333.

DH has been the subject of a number of analyst reports. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. Robert W. Baird set a $4.00 price objective on shares of Definitive Healthcare in a report on Friday, August 8th. Finally, Stifel Nicolaus boosted their target price on shares of Definitive Healthcare from $5.00 to $6.00 and gave the stock a "buy" rating in a research note on Friday, August 8th.

Hedge Funds Weigh In On Definitive Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Raymond James Financial Inc. acquired a new stake in Definitive Healthcare during the second quarter worth approximately $32,000. Farther Finance Advisors LLC acquired a new stake in Definitive Healthcare during the 2nd quarter worth $33,000. Bayesian Capital Management LP purchased a new stake in Definitive Healthcare in the fourth quarter valued at $41,000. Savant Capital LLC acquired a new position in Definitive Healthcare in the second quarter valued at $45,000. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Definitive Healthcare during the second quarter worth about $51,000. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Stock Down 3.9%

Shares of Definitive Healthcare stock traded down $0.16 during trading hours on Friday, reaching $3.98. 259,683 shares of the company were exchanged, compared to its average volume of 276,527. The firm has a market cap of $569.70 million, a PE ratio of -1.50 and a beta of 1.65. The stock's fifty day moving average is $3.96 and its 200 day moving average is $3.43. Definitive Healthcare has a 1 year low of $2.15 and a 1 year high of $5.68. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.